Hamit Sırrı KETEN, Soner ÖLMEZ, Hüseyin ÜÇER, Oğuz IŞIK, Fatis YILDIRIM, Mustafa ÇELİK

Maraş otu (dumansız tütün) kullanımının kan basıncı ve kalp hızı üzerine akut etkileri

Amaç: Bu çalışmada Maraş otu (dumansız tütün) kullanımının kan basıncı ve kalp hızı üzerine akut etkisinin belirlenmesi amaçlanmıştır.Gereç ve Yöntem: Bu çalışma Kahramanmaraş ilindeki 20 kıraathanede, 140 gönüllü erkek üzerinde yapıldı. Brakiyal sistolik kan basıncı, diastolik kan basıncı ve kalp hızı, sol koldan otomatik dijital osilometrik cihaz ile ölçüldü. Katılımcıların on beş dakikalık dinlenmeyi takiben yapılan ilk kalp hızı, sistolik kan basıncı ve diastolik kan basıncı ölçümü bazal olarak kabul edildi. Bazal ölçüm sonrası katılımcıların 5, 10, 15 ve 20.dakikalarda tekrar kalp hızı, sistolik kan basıncı ve diastolik kan basıncı ölçümü yapıldı. Bazal ölçümün hemen sonrasında, katılımcıların 1.5 gram Maraş otunu alt dudağın iç kısmında 10 dakika bekletmesi sağlandı. 5 ve 10. dakikada yapılan ölçümler Maraş otu ağızda iken yapıldı. 10. dakika yapılan ölçümün hemen sonrasında Maraş otu ağızdan çıkarıldı.Bulgular: Çalışmamızda katılımcıların 5, 10, 15 ve 20.dakikalarda yapılan ölçümlerde kalp hızı, sistolik kan basıncı ve diastolik kan basıncının bazala göre anlamlı seviyede yüksek olduğu tespit edildi. Sonuç: Çalışmamızda Maraş otu kullanıcılarında, Maraş otu kullanımının akut olarak kalp hızı, sistolik kan basıncı ve diastolik kan basıncını anlamlı olarak yükselttiğini ortaya konulmuştur.

Anahtar Kelimeler:

Kan basıncı, kalp hızı, dumansız tütün, Maraş otu

Acute effects of Maras powder (smokeless tobacco) on blood pressure and heart rate

Purpose: The aim of this study was to determine the acute effects of Maras powder on blood pressure and heart rate.Material and Methods: This study was conducted in 20 cafés in Kahramanmaras city on 140 voluntary males. Brachial systolic blood pressure, diastolic blood pressure and the heart rate were measured from the left arm by automated digital oscillometric device. The first heart rate, systolic blood pressure and diastolic blood pressure after a relaxing period of 15 minutes were accepted as the basal values. After the basal measurement, following measurements were performed on 5th, 10th, 15th and 20th minutes. Following initial measurement, the participants were made to place and keep 1.5 grams of Maras powder between the gingiva and the lower lip for 10 minutes. The measurements of the 5th and 10th minutes were performed when Maras powder was still in participants’ mouths. After measurement of the 10th minute, Maras powder was taken out of the participants’ mouths. Results: Heart rate, systolic blood pressure anddiastolic blood pressure values of 5th, 10th, 15th and 20th minutes were significantly higher compared to basal measurements.Conclusion: We revealed that Maras powder increased the heart rate, systolic blood pressure and diastolic blood pressure acutely and significantly in our study.

Keywords:

Blood pressure, heart rate, smokeless tobacco, Maras powder,

PDF

___

1. Christen AG, Swanson BZ, Glover ED, Henderson AH. Smokeless tobacco: the folklore and social history of snuffing, sneezing, dipping and chewing. J Am Dent Assoc. 1982;105:821-9.
2. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package. Geneva, World Health Organization, 2008.WHO Report 008.
3. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Rockville, MD, SAMHSA, Office of Applied Studies, 2010.
4. Idris AM, Prokopczyk B, Hoffmann D. Toombak: A major risk factor for cancer of the oral cavity in Sudan. Prev Med. 1994;23:832-9.
5. Official Statistics of Sweden. Living Conditions Report No 114. Use of alcohol and tobacco. Stockholm, Sweden: Statistics Sweden, Unit of Social Welfare, 2007.
6. Kafas A. Analysis of factors affecting cigarete smoking and Maras powder use among adults in the urban area of Kahramanmaras (Master’s thesis). Kahramanmaraş, Kahramanmaras Sutcu Imam University, 2011,
7. Keten HS, Çelik M, Ersoy Ö, Üçer H, Işık O. Knowledge, attitudes and behaviors of patients with chronic diseases about smoking and use of Maras powder. Cukurova Medical Journal. 2016;41:121-8.
8. Keten HS, Kuş C, Ölmez S, Batuş A, Çelik M, Sucaklı MH. Effectiveness of treatment for quitting smoking and Maras powder use in patients aged sixty years or older. Turk J Geriatr. 2014;17:272-7.
9. Aral M, Ekerbicer H, Celik M, Ciragil P, Gul M. Comparison of effects of smoking and smokeless tobacco “Maras powder” use on humoral immune system parameters. Mediators Inflamm. 2006;2006:85019.
10. Keten HS. Bupropion for the treatment smoke and Maras powder (smokeless tobacco) addiction. J Contemp Med. 2014;4:CR-100.
11. Erenmemisoglu A. Re: Turkish smokeless tobacco “Maras powder”. Prev Med. 1999;28:616-7.
12. Keten D, Keten HS, Goktas MT, Ucer H, Ersoy O, Celik M. Oral Candida carriage and prevalence of Candida species among Maras powder users and non-users.J Oral Pathol Med. 2015;44:502-6.
13. Benowitz NL, Jacob P, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther. 1982;221:368-72.
14. De Cesaris R, Ranieri G, Filitti V, Bonfantino MV, Andriani A. Cardiovascular effects of smoking. Cardiology. 1992;81:233–7.
15. Pandey A, Patni N, Sarangi S, Singh M, Sharma K, Vellimana AK et al. Association of exclusive smokeless tobacco consumption with hypertension in an adult male rural population of India. Tobacco Induced Diseases. 2009;5:15.
16. Gupta BK, Kaushik A, Panwar RB, Chaddha VS, Nayak KC, Singh VB et al. Cardiovascular risk factors in tobacco-chewers: a controlled study. J Assoc Physicians India. 2007;55:27-31.
17. Green MS, Harari G. A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body eight and blood pressure in occupationally active men: the Israeli cordis study. J Clin Epidemiol. 1995;48:1159-66.
18. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension. 2001;37:187-93.
19. Ragueneau I, Michaud P, Démolis JL, Moryusef A, Jaillon P, Funck-Brentano C. Effects of cigarette smoking on short-term variability of blood pressure in smoking and non smoking healthy volunteers. Fundam Clin Pharmacol. 1999;13:501-7.
20. Boucher BJ, Mannan N. Metabolic effects of the consumption of Areca catechu. Addict Biol. 2002;7:103-10.
21. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322:531-6.
22. Güven A, Köksal N, Büyükbeşe MA, Çetinkaya A, Sökmen G, Aksu E et al. Effects of using a different kind of smokeless tobacco on cardiac parameters: “Maras powder”. Anadolu Kardiyol Derg. 2003;3:230-5.
23. Kılınç M, Okur E, Kurutas EB, Güler FI, Yıldırım I. The effects of maras powder (smokeless tobacco) on oxidative stres in users. Cell Biochem Funct. 2004;22:233-6.
24. Sucakli MH, Ozkan F, Inci MF, Celik M, Keten HS et al. Effects of smokeless tobacco (Maras powder) use on carotid intima media thickness. Med Sci Monit. 2013;19:859-64.
25. Wolk R, Shamsuzzaman ASM, Svatikova A, Huyber CM, Huck C et al. Hemodynamic and autonomic effects of smokeless tobacco in healthy young men. J Am Coll Cardiol. 2005;45:910-4.
26. Martin JS, Beck DT, Gurovich AN, Braith RW. The acute effects of smokeless tobacco on central aortic blood pressure and wave reflection characteristics. Exp Biol Med (Maywood). 2010;235:1263-8.
27. Ramakrishnan S, Thangjam R, Roy A, Singh S, Ramakrishnan L, Seth S et al. Acute effects of tobacco chewing on the systemic, pulmonary and coronary circulation. Am J Cardiovasc Drugs. 2011;11:109-14.
28. Garcia Calzado MC, Garcia Rojas JF, Mangas A, Martinez Izquierdo D, Repetto M et al. Determinaciones plasmaticas de nicotina y cotinina: marcadores biologicos del tabaco. Rev San Hig Pub. 1991;65:437-43.
29. Ilgenli TF, Akpınar O. Acute effects of smoking on rightventricular function: a tissue Doppler imaging study on healthy subjects. Swiss Med Wkly. 2007;137:91-6.
30. Shafagoj YA, Mohammed FI, Hadidi KA. Hubble-bubble (water pipe) smoking: Levels of nicotine and cotinine in plasma, saliva and urine. Int J Clin Pharmacol Ther. 2002;40:249-55.
31. Winniford MD, Wheelan KR, Kremers MS, Ugolini V, van den Berg E et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation. 1986l;73:662-7.
32. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smokingassociated hemodynamic and metabolic events. New Engl J Med. 1976;295:573-7.